Hermann A. M. Mucke
H.M. Pharma Consultancy
Austria
Name/email consistency: high
- Iguratimod: a new disease-modifying antirheumatic drug. Mucke, H.A. Drugs. Today (2012)
- Current drug patenting for retinal diseases: beyond VEGF inhibitors. Mucke, H.A., Mucke, P.M. IDrugs (2010)
- Small-molecule endothelin receptor antagonists: a review of patenting activity across therapeutic areas. Mucke, H.A. IDrugs (2009)
- Pulmonary arterial hypertension: on the way to a manageable disease. Mucke, H.A. Curr. Opin. Investig. Drugs (2008)
- New ocular therapeutics: a view from the patenting perspective. Mucke, H.A. IDrugs (2007)
- CEP-1347 (Cephalon). Mucke, H.A. IDrugs (2003)
- Genomics and dementia--new drug targets ahead?. Mucke, H.A. J. Neural Transm. Suppl. (2002)
- Therapies in development for the treatment of migraine. Mucke, H. Expert. Opin. Investig. Drugs (2002)
- Frovatriptan Vernalis. Mucke, H.A. Curr. Opin. Investig. Drugs (2002)
- Localization and function of 5-HT2 receptors. Mucke, H.A. IDrugs (2002)
- Sixth COngress of the European Federation of Neurological Societies. Mucke, H. IDrugs (2002)
- TAK-147 (Takeda). Mucke, H. Curr. Opin. Investig. Drugs (2001)